Molecular Pathology, Diagnostics, and Therapeutics

Special Issues

Following special issues within this section are currently open for submissions:

• Molecular Mechanisms of Acquiring Resistance to Treatments in Prostate Cancer: Perspectives of Old and New Organelles (Deadline: 15 October 2024)
• Hypertension: Mechanisms of Oxidative Stress and Antioxidant Regulation (Deadline: 15 October 2024)
• Novel MSC Perspectives: From Cell Regulation to Tissue Regeneration 4.0 (Deadline: 15 October 2024)
• Melanoma: From Molecular Pathology to Therapeutic Approaches (Deadline: 15 October 2024)
• Novel Molecular Targets and Prognostic Markers Focused on Improving Quality in Healthcare (Deadline: 15 October 2024)
• Cutaneous Biology, Molecular Dermatology and Dermatopathology (Deadline: 20 October 2024)
• Pathophysiology of the Serotonin System in the Nervous System and Beyond—2nd Edition (Deadline: 20 October 2024)
• The Role of Specific Alteration in Neurological Disorders: From Molecular Mechanisms to Therapeutic Strategies (Deadline: 20 October 2024)
• The Cross-Knit between Immune Cells and Thyroid Function in Autoimmune Thyroid Disorders (Deadline: 20 October 2024)
• The Bidirectional Biological Interaction Between Periodontal Disease and Diabetes Mellitus (Deadline: 20 October 2024)
• Molecular Basic Research in Cardiology (Deadline: 20 October 2024)
• Colorectal Cancers: An Update on Their Molecular Pathology and Therapy (Deadline: 20 October 2024)
• Calcification in Human Diseases: Pathological Aspects and Therapeutic Strategies (Deadline: 20 October 2024)
• Molecular Research of Hepatocellular Carcinoma (Deadline: 20 October 2024)
• Molecular Mechanisms and Treatment of Cardiovascular Diseases (Deadline: 20 October 2024)
• Physiopathology of Connective Tissue: Regenerative Perspective (Deadline: 20 October 2024)
• Emerging Concepts in Neurodegeneration Research (Deadline: 20 October 2024)
• Molecular Mechanisms of Retina Degeneration (Deadline: 20 October 2024)
• Arteriogenesis, Angiogenesis and Vascular Remodeling, 2nd Edition (Deadline: 20 October 2024)
• Biomarkers for the Diagnosis and Prognosis of Cardiovascular Disease (Deadline: 20 October 2024)
• Unlocking the Future of Muscle Disease Treatment: Advancements in Gene Therapy, Antisense Therapeutics and Cutting-Edge Pharmacological Strategies (Deadline: 20 October 2024)
• Targeting Collagen-Related Therapy (Deadline: 20 October 2024)
• Advancements in Molecular Research on Infertility (Deadline: 20 October 2024)
• Skeletal Muscle Function and Metabolism: Molecular Mechanisms and Treatment (Deadline: 20 October 2024)
• Molecular Mechanisms of Tumor-Induced Cardiac Diseases (Deadline: 20 October 2024)
• Molecular Advances in Bone Metabolism and Disorders (Deadline: 20 October 2024)
• Molecular Pathogenesis and Therapies for Retinal and Optic Nerve Diseases (Deadline: 20 October 2024)
• Molecular Pathology Research on Pregnant Uterus, Uterine Infections and Diseases (Deadline: 20 October 2024)
• Molecular Research of Gastrointestinal Disease 2.0 (Deadline: 20 October 2024)
• Recent Advances in Molecular Pathophysiology of Cardiovascular Diseases: 2nd Edition (Deadline: 20 October 2024)
• The Human Fetal Membranes: A Versatile Tissue Important for Pregnancy Health and Regenerative Therapies (Deadline: 20 October 2024)
• Impact of Endotoxemia on Chronic Non-communicable Diseases (Deadline: 20 October 2024)
• Emerging Molecular Research on Skin Cancer and Inflammatory Skin Diseases (Deadline: 20 October 2024)
• Emerging Roles of Inflammation in Retinal and Optic Nerve Pathologies (Deadline: 20 October 2024)
• Molecular Research in Breast Cancer: Pathophysiology and Treatment (Deadline: 20 October 2024)
• Molecular Mechanisms and Therapeutic Strategies of Inflammatory Pain (Deadline: 20 October 2024)
• Molecular Insight into Gestational Diabetes Mellitus (Deadline: 20 October 2024)
• Short and Long-Term Profound Acid Inhibition: Indications and Concerns (Deadline: 20 October 2024)
• Advancements in Osteoarthritis and Cartilage Regeneration: Pathophysiology and Molecular Mechanisms (Deadline: 20 October 2024)
• Molecular and Vascular Biology: From Pathophysiology to Therapy (Deadline: 20 October 2024)
• Molecular Mechanisms of Interleukin/Cytokines in Psychiatric Disorders (Deadline: 20 October 2024)
• Retinal Degenerative Diseases: 2nd Edition (Deadline: 20 October 2024)
• New Insights into the Molecular Mechanisms of Chronic Pain (Deadline: 20 October 2024)
• New Challenges of Parkinson’s Disease (Deadline: 20 October 2024)
• Precision Medicine Cystic Fibrosis (Deadline: 20 October 2024)
• Sleep Apnea and Intermittent Hypoxia (Deadline: 20 October 2024)
• Heart Failure: From Molecular Pathology to Novel Therapeutic Approach (Deadline: 20 October 2024)
• Obesity: From Molecular Mechanisms to Clinical Aspects (Deadline: 20 October 2024)
• Interrelation between Heart Failure and Chronic Kidney Disease: A Focus on Molecule Mechanisms (Deadline: 20 October 2024)
• Exploring Molecular Mechanisms of Liver Fibrosis (Deadline: 20 October 2024)
• Molecular Insights into Atherosclerosis and Vascular Endothelial Cells (Deadline: 20 October 2024)
• Molecular Mechanisms and Pathophysiology of Sepsis (Deadline: 20 October 2024)
• Molecular Research in Uterine Biology and Pathophysiology, 2nd Edition (Deadline: 20 October 2024)
• State-of-the-Art Molecular Mechanisms of Pulmonary Pathology (Deadline: 20 October 2024)
• Retinal Diseases and Macular Degeneration: Cell Biology and Molecular Genetics (Deadline: 20 October 2024)
• Apoptosis in Cancer Cells and New Targets for Cancer Therapy (Deadline: 20 October 2024)
• Molecular Advances in Melanoma Therapy (Deadline: 20 October 2024)
• Highlights in Pathophysiology of the Musculoskeletal System 2.0 (Deadline: 20 October 2024)
• New Concepts in Platelet Activation and Thrombus Formation (Deadline: 20 October 2024)
• Strategies to Fight Metabolic Diseases (Deadline: 20 October 2024)
• Cell Signaling and Molecular Pathology of Retinal Diseases : 2nd Edition (Deadline: 25 October 2024)
• Skin Diseases: From Molecular Pathology to Novel Therapeutic Approaches (Deadline: 25 October 2024)
• Recent Molecular Trends and Prospects in Kidney Diseases (Deadline: 25 October 2024)
• Dental Health and Disease: From the Molecular and Pathological Perspectives (Deadline: 25 October 2024)
• Molecular and Cellular Mechanisms of Retinal Diseases (Deadline: 28 October 2024)
• Mitochondrial Biology and Reactive Oxygen Species (Deadline: 28 October 2024)
• Endometrial Function in Women with Polycystic Ovary Syndrome: Molecular Data (Deadline: 30 October 2024)
• Molecular and Therapeutic Research in Rheumatoid Arthritis, 2nd Edition (Deadline: 30 October 2024)
• Molecular Insights into the Obstetrics and Gynecology (Deadline: 30 October 2024)
• Interactions of Microbiome in Skin, Gastrointestinal, and Mucocutaneous Diseases (Deadline: 30 October 2024)
• Molecular Research in Retinal Degeneration (Deadline: 30 October 2024)
• New Insights in Kawasaki Disease (Deadline: 30 October 2024)
• The Relationship, Mechanisms, and Treatment Strategies of Diabetes Mellitus and Related Diseases (Deadline: 30 October 2024)
• Molecular Advances in Blood Disorders (Deadline: 30 October 2024)
• Molecular Interactions in Inflammatory Skin Diseases (ISDs): The Role of Exosomes and Other Molecular Mediators in Pathogenesis and Therapeutic Strategies (Deadline: 30 October 2024)
• New Insights into the Roles of Cellular Plasticity in Disease (Deadline: 30 October 2024)
• Atherosclerosis: From Molecular Biology to Therapeutic Perspective: 6nd Edition (Deadline: 30 October 2024)
• The Impact of Vascular Dysfunction in Obesity and Diabetes (Deadline: 30 October 2024)
• Neurological Disorders: Molecular Pathology and Therapeutic Approaches (Deadline: 30 October 2024)
• Challenges and Future Trends of Inflammatory Skin Diseases Treatment, 2nd Ediion (Deadline: 30 October 2024)
• Cellular and Molecular Mechanisms in Oxidative Stress-Related Diseases 4.0 (Deadline: 30 October 2024)
• Molecular Advances in Dry Eye Syndrome (Deadline: 31 October 2024)
• Inflammation and Cellular Senescence in Age-Related Diseases (Deadline: 31 October 2024)
• Endometriosis: From Molecular Basis to Therapy (Deadline: 31 October 2024)
• Translational Research in Angiogenesis—a Key Tool for Developing Therapeutic Strategies towards Tissue Regeneration (Deadline: 31 October 2024)
• Rare Genetic Diseases: From Molecular Mechanisms to Therapeutic Strategies (Deadline: 31 October 2024)
• Pediatric Diseases: From Molecular Mechanisms to Novel Therapeutic Strategies (Deadline: 31 October 2024)
• From Basic Science to Treatment Strategies: Personalized Cancer Therapy, 2nd Edition (Deadline: 31 October 2024)
• Cardiovascular Diseases: From Pathology to Therapeutics (Deadline: 31 October 2024)
• Cancer Stem Cells in Solid Tumors (Deadline: 31 October 2024)
• Musculoskeletal Disease: From Molecular Basis to Therapy (Deadline: 31 October 2024)
• Heart Failure Mechanisms and Treatment Advances (Deadline: 31 October 2024)
• Molecular Advances in Burn and Wound Healing (Deadline: 31 October 2024)
• Molecular Insights into Reproductive Biology and Related Diseases (Deadline: 31 October 2024)
• Lung Diseases Molecular Pathogenesis and Therapy (Deadline: 31 October 2024)
• Endometriosis and Infertility (Deadline: 31 October 2024)
• Skin Diseases: From Molecular Mechanisms to Pathology (Deadline: 31 October 2024)
• Advances in Coagulation and Anticoagulation (Deadline: 31 October 2024)
• Molecular Research on Skeletal Muscle Metabolism and Diseases (Deadline: 31 October 2024)
• Molecular Mechanisms and Pathophysiology of Myocardial Disease (Deadline: 31 October 2024)
• Molecular Advances and Insights on Diagnosis, Prevention and Therapeutics of Cardiovascular Diseases (Deadline: 31 October 2024)
• Molecular Mechanisms of Musculoskeletal Involvement in Rare Diseases (Deadline: 31 October 2024)
• Unravelling Interactions between Amyloid Beta (Aβ) and Key Pathological Features of Alzheimer’s Disease (Deadline: 31 October 2024)
• Molecular Research in Gynecological Diseases—2nd Edition (Deadline: 31 October 2024)
• MAPK Signaling Cascades in Human Health and Diseases 2.0 (Deadline: 31 October 2024)
• Therapeutic Target in Cardiovascular Disease (Deadline: 31 October 2024)
• Glutamine Metabolism in Cancer (Deadline: 31 October 2024)
• Medical Imaging Technology in Molecular Pathological Mechanisms and Disease Therapies (Deadline: 31 October 2024)
• Circadian Rhythms in the Molecular Pathogenesis of Chronic Diseases: Implications for Prevention and Therapeutic Strategies (Deadline: 31 October 2024)
• New Wave of Cancer Therapeutics: Challenges and Opportunities (Deadline: 31 October 2024)
• Prostate Cancer: Novel Research and Innovative Therapeutic Strategies (Deadline: 31 October 2024)
• Recent Research on Vitamin D Metabolism in Disease (Deadline: 31 October 2024)
• Molecular Insights into the Developmental Origins of Health and Disease (Deadline: 31 October 2024)
• Mass Spectrometry Approaches as Clinical Diagnostic/Prognostic Tools (Deadline: 31 October 2024)
• Advances in Molecular Research of Cartilage: 2nd Edition (Deadline: 31 October 2024)
• Cell and Molecular Perspectives in Breast Cancer (Deadline: 31 October 2024)
• Molecular Studies of Hematological Malignancies: Emphasis on Development of Flow-Cytometry and Cell-Sorting-Based Technics for Improving Diagnosis (Deadline: 31 October 2024)
• Recent Advances in Hypertension and Cardiovascular Disease 2.0 (Deadline: 31 October 2024)
• Translational Research in Ophthalmic Pathology (Deadline: 31 October 2024)
• Protein Kinase in Disease 2.0 (Deadline: 31 October 2024)
• Genetics of Disease and Health Outcomes under the Influence of Environmental Factors (Deadline: 31 October 2024)
• Lymphedema: From Mechanism to Treatment (Deadline: 31 October 2024)
• Cardioprotection and Mitochondrial Signaling: Insights from Molecular Mechanisms to Therapeutic Strategies (Deadline: 31 October 2024)
• Chronic Kidney Disease: The State of the Art and Future Perspectives (Deadline: 31 October 2024)
• Beyond Transgenics: Leveraging Humanized Mice for Disease Modeling and Therapeutics (Deadline: 31 October 2024)
• Molecular and Pathophysiological Insights into the Pleiotropic Role of SGLT2i (Deadline: 31 October 2024)
• Molecular Insights and Epigenetic Factors in Aging and Age-Related Diseases (Deadline: 31 October 2024)
• Regulation of Ion Channels and Transporters in Related Diseases (Deadline: 31 October 2024)
• Genetic Basis and Molecular Mechanisms of Heart Failure (Deadline: 31 October 2024)
• New Insights into Adipose Tissue Metabolic Function and Dysfunction, 3rd Edition (Deadline: 31 October 2024)
• Molecular Pathogenesis and Diagnostics of Lung Diseases (Deadline: 31 October 2024)
• Molecular Mechanisms and Novel Therapies of Liver Diseases (Deadline: 31 October 2024)
• Cardiovascular Disease and Diabetes: A New Challenge in Treatment and Management (Deadline: 31 October 2024)
• Molecular Advances in Myocardial Fibrosis (Deadline: 1 November 2024)
• Therapeutic Potential: Exploring Membrane Transporters and Channels as Drug Targets (Deadline: 10 November 2024)
• Radiation, Oxidative Stress and Damage Related Normal Tissue Complications: Mechanisms and Strategies to Mitigate (Deadline: 15 November 2024)
• Virus and Cancers: Association with the Disease and Therapies (Deadline: 20 November 2024)
• Cellular and Molecular Targets of Preeclampsia (Deadline: 20 November 2024)
• Inflammatory Bowel Diseases: Molecular Mechanism and Therapeutics (Deadline: 20 November 2024)
• Pathogenetic Factors of Ophthalmological Symptoms in Systemic Diseases (Deadline: 20 November 2024)
• Cellular and Molecular Biology of Cardiac Hypertrophy and Heart Failure: Pathogenesis, Diagnostics and Treatment (Deadline: 20 November 2024)
• Male Genitourinary Tumors: Molecular and Cellular Mechanism (Deadline: 20 November 2024)
• Understanding Allergy and Asthma at the Molecular Level (Deadline: 20 November 2024)
• New Advances in Proteomics in Disease (Deadline: 20 November 2024)
• Cardiomyopathy: From Pathologies to Therapy (Deadline: 20 November 2024)
• Novel Insight into Pulmonary Vascular Disease (Deadline: 20 November 2024)
• Advanced Progress and Application of Photodynamic Therapy (Deadline: 20 November 2024)
• Advanced Molecular Mechanisms and Technologies in Cardiac Regeneration (Deadline: 20 November 2024)
• Oral Cancer and Disease in Humans and Animals (Deadline: 20 November 2024)
• Molecular Biosensors for the Early Detection of Human Diseases (Deadline: 20 November 2024)
• Comprehensive Insights into Molecular Mechanisms and Pathophysiology of Spinal Cord Injury (Deadline: 20 November 2024)
• Lung Cancers: An Update on Molecular Diagnostics and Therapy (Deadline: 20 November 2024)
• Advances on Retinal Diseases: 2nd Edition (Deadline: 20 November 2024)
• Epilepsy: Molecular Mechanisms and Therapies (Deadline: 20 November 2024)
• New Advances in Thrombosis: 3rd Edition (Deadline: 20 November 2024)
• Molecular Linkage between Atherosclerosis and Extracellular Vesicles (Deadline: 20 November 2024)
• Advances in Therapeutics against Eukaryotic Pathogens (Deadline: 20 November 2024)
• Molecular Research on Prostate Cancer (Deadline: 20 November 2024)
• Mesenchymal Stem/Stromal Cells and Hematological Diseases (Deadline: 20 November 2024)
• Obesity and Malignancies in Women: Searching for New Molecular Links (Deadline: 20 November 2024)
• Chronic Liver Disease: Latest Research in Pathogenesis, Detection and Treatment, 2nd Edition (Deadline: 20 November 2024)
• Molecular and CelluIar Mechanisms of Valvular Heart Disease (Deadline: 20 November 2024)
• From Molecular Mechanism to Therapy in Autism Spectrum Disorder: 2nd Edition (Deadline: 20 November 2024)
• Updates on Prostate Cancer Research: Molecular Diagnostic Biomarker (Deadline: 20 November 2024)
• New Insights into Glioblastoma: Cellular and Molecular (2nd Edition) (Deadline: 20 November 2024)
• Autophagy and Kidney Diseases (Deadline: 20 November 2024)
• Pathogenesis and Novel Therapeutics in Breast Cancer (Deadline: 20 November 2024)
• Advanced Research on Wound Healing 2.0 (Deadline: 20 November 2024)
• Osteoarthritis Biomarkers, Diagnosis and Treatments (Deadline: 20 November 2024)
• Towards Personalized Treatment and Molecular Research on Colorectal Cancer (Deadline: 20 November 2024)
• New Perspective in the Molecular Pathways Involved in Acute and Chronic Lung Injury (Deadline: 20 November 2024)
• Molecular Advances and Therapeutic Strategies in Renal Failure (Deadline: 20 November 2024)
• Research on Mitochondria and Cell Death in Disease Diagnosis and Treatment (Deadline: 20 November 2024)
• Lysosomal Storage Disorders: Pathophysiology, Molecular Mechanism and Therapeutic Strategies (Deadline: 20 November 2024)
• Atherosclerosis 2.0: From Molecular Mechanisms, Pathophysiology to Novel Therapeutic Approaches (Deadline: 20 November 2024)
• Advanced Molecular Research in Lung Diseases (Deadline: 20 November 2024)
• Metabolic Mechanisms of Cardiac Injury (Deadline: 20 November 2024)
• Complications of Pregnancy: The Importance of Omics-Based Diagnosis and Therapeutic Approaches (Deadline: 20 November 2024)
• Bioactive Lipids and Their Derivatives in Biomedical Applications (Deadline: 20 November 2024)
• Mitochondrial Dysfunction: A Metabolic, Cardiovascular, Neurodegenerative and Neuromuscular Issue: 2nd Edition (Deadline: 20 November 2024)
• Viral Diseases of the Respiratory System—Molecular Mechanisms and Pathogenesis 2.0 (Deadline: 20 November 2024)
• Novel Targeted Therapies and Drugs in Cancer (Deadline: 20 November 2024)
• Molecular Mechanism and Pathophysiology of Pain (Deadline: 25 November 2024)
• Forward in Vasculitis: Genetics and Beyond (Deadline: 25 November 2024)
• Recent Advances in Molecular Mechanisms Underlying Kidney Diseases: Pathophysiology and Therapeutic Targets, 2nd Edition (Deadline: 25 November 2024)
• Advances in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), 2nd Edition (Deadline: 30 November 2024)
• Molecular Linkages between Obesity, Diabetes and Cancer (Deadline: 30 November 2024)
• Molecular Mechanisms and Therapeutic Targets in Skin Diseases (Deadline: 30 November 2024)
• Innovations in Seizure Management: Exploring New Antiseizure Medications and Targeted Therapies (Deadline: 30 November 2024)
• Advances in Heart Diseases: Molecular Pathogenesis, Biomarkers and Therapies (Deadline: 30 November 2024)
• Gynecological Cancer: Targeted Therapeutics and Future Perspectives (Deadline: 30 November 2024)
• Molecular Advances in Heart Disease: Genomics, Proteomics, and Bioinformatics of Heart Research (Deadline: 30 November 2024)
• Organoids and Organs-on-Chip for Medical Research (Deadline: 30 November 2024)
• Dermatology: Advances in Pathophysiology and Therapies (2nd Edition) (Deadline: 30 November 2024)
• Molecular Mechanism and Pathogenesis of Cardiac Disease (Deadline: 30 November 2024)
• Advancements and Applications of Phyto-Nanotherapy in Targeted Disease Treatment (Deadline: 30 November 2024)
• Advances in Molecular Pathophysiology of Diabetes, Hypertension and Cardiovascular Diseases (Deadline: 30 November 2024)
• Molecular Findings in Colorectal Cancer (Deadline: 30 November 2024)
• Molecular Diagnostics and Treatment of Inflammatory Bowel Disease (Deadline: 30 November 2024)
• Primary and Secondary Bladder Disorders in Neurourology and Inflammatory Diseases (Deadline: 30 November 2024)
• Sepsis and Septic Shock: From Molecular Mechanisms to Novel Therapies—2nd Edition (Deadline: 30 November 2024)
• Molecular Mechanisms and Treatment Strategies of Myocardial Infarction (Deadline: 30 November 2024)
• Tissue Regeneration and Repair in Airway Diseases (Deadline: 30 November 2024)
• Molecular Biomarkers in Cancers: Advances and Challenges, 2nd Edition (Deadline: 30 November 2024)
• Impact of Circulatory and Blood Clotting Dysfunctions in Infectious Diseases (Deadline: 30 November 2024)
• Molecular Aspects of Heart Failure: Identifying New Drugs and Therapy Targets (Deadline: 30 November 2024)
• Cell Organelle Stress Responses and Implications in Human Diseases (Deadline: 30 November 2024)
• Advanced Molecular Research on Chronic Heart Failure (Deadline: 30 November 2024)
• Hematologic Diseases: Molecular Insights and Novel Methods (Deadline: 30 November 2024)
• Novel Insights into the Molecular Bases of Congenital Eye Abnormalities (Deadline: 30 November 2024)
• Innovative In Vitro Model for Medical, Pharmaceutical and Diagnostic Applications (Deadline: 30 November 2024)
• Molecular and Translational Research in Cardiovascular Endocrinology, Cardio-Metabolic Diseases and Non-alcoholic Fatty Liver Disease (NAFLD): 2nd Edition (Deadline: 30 November 2024)
• Protein Folding, Misfolding, and Related Diseases (Deadline: 30 November 2024)
• Molecular Research on Kidney Disease/Renal Dysfunction (Deadline: 30 November 2024)
• Inflammatory Biomarkers in Ischemic Stroke (Deadline: 30 November 2024)
• New Targeted Therapies in Cancer: 2nd Edition (Deadline: 30 November 2024)
• Growth Hormone Deficiency: Molecular Pathologies and Therapeutic Strategies (Deadline: 30 November 2024)
• Molecular Mechanisms and Therapeutic Targets for Pain Regulation (Deadline: 30 November 2024)
• Wheat-Related Intestinal Diseases: From Molecular Basis to Potential Therapy (Deadline: 30 November 2024)
• Transcription Factors in Lung Cancer: Mechanisms and Future Perspectives (Deadline: 30 November 2024)
• Old and New Gateways to Liver Diseases (Deadline: 30 November 2024)
• Treatment Resistance and Current Advances in Cancer Immunotherapy (Deadline: 30 November 2024)
• Molecular Advances in Ovarian Cancer: 2nd Edition (Deadline: 30 November 2024)
• Lung Diseases: Molecular Insights and Advancements (Deadline: 30 November 2024)
• Pathophysiology of Hair Loss (Deadline: 30 November 2024)
• Diagnosis and Treatment of Osteoporosis (Deadline: 30 November 2024)
• Current Molecular Progress on Cell and Gene Therapies (Deadline: 30 November 2024)
• Autophagy, Cellular Senescence and Oxidative Stress in Ageing and Age-Related Diseases (Deadline: 30 November 2024)
• Diagnosis and Monitoring of Kidney Disease: From Biology to Biomarkers (Deadline: 30 November 2024)
• Molecular Diagnosis and Therapy of Non-Small-Cell Lung Cancer (Deadline: 30 November 2024)
• Advanced Research on Regenerative Medicine (Deadline: 30 November 2024)
• Chromosome Transfer: Advances in Stem Cell-Based Gene Therapy (Deadline: 30 November 2024)
• Molecular Therapeutics for Diabetes and Related Complications (Deadline: 30 November 2024)
• Molecular Perspective of Cardiovascular Diseases (Deadline: 30 November 2024)
• Novel Insight into Microcirculation and Microvascular Diseases (Deadline: 30 November 2024)
• The Endocannabinoid System: New Insights into Its Role in Health and Disease 2.0 (Deadline: 30 November 2024)
• Challenges of Immune Checkpoint Inhibitor Therapy (Deadline: 30 November 2024)
• Pathophysiology and Advanced Treatment of Hematological Malignancy (Deadline: 30 November 2024)
• Advances in Lupus Erythematosus and Lupus Nephritis: Pathogenesis, Biomarkers and Treatments (Deadline: 30 November 2024)
• Autophagy in Alzheimer's Disease and Its Models: Treatment Options (Deadline: 30 November 2024)
• Physiological and Pathological Hypoxia: The Battle between the Protective and Deleterious Effects of Oxygen Deprivation (Deadline: 10 December 2024)
• Molecular Research in Aggressive Behavior (Deadline: 13 December 2024)
• Molecular Pathogenesis and Treatment of Pregnancy Complications (Deadline: 15 December 2024)
• New Research Insights in Cystic Fibrosis and CFTR-Related Diseases (Deadline: 15 December 2024)
• Insights into Oral Squamous Cell Carcinoma (Deadline: 20 December 2024)
• Research Progress on the Mechanism and Treatment of Cardiomyopathy (Deadline: 20 December 2024)
• Targeting Blood Vessels in Cancer and Fibrosis (Deadline: 20 December 2024)
• Regeneration for Spinal Diseases 4.0 (Deadline: 20 December 2024)
• Molecular Studies of Bone Biology and Bone Tissue (Deadline: 20 December 2024)
• Molecular Advances in Pediatric Diseases (Deadline: 20 December 2024)
• Brain Metastasis 2024 (Deadline: 20 December 2024)
• Molecular Insights into Kidney Injury and Repair (Deadline: 20 December 2024)
• Ischemia Reperfusion Injury: A Cell Signaling Crossroads and Therapeutics 2.0 (Deadline: 20 December 2024)
• Innovations in Molecular Treatment of Hematological Malignancies (Deadline: 20 December 2024)
• Molecular Biology of Liver Diseases: Pathogenesis, Diagnostics and Treatment (Deadline: 20 December 2024)
• Cellular and Molecular Research of Kidney Diseases—2nd Edition (Deadline: 20 December 2024)
• Cellular and Molecular Insights into Ocular Changes Associated with Systemic Disorders and Conditions (Deadline: 20 December 2024)
• Molecular Research on Thyroid and Thyroid Nodules (Deadline: 20 December 2024)
• Roles of Extracellular Vesicles in Cerebrovascular Diseases (Deadline: 20 December 2024)
• Cellular and Molecular Mechanisms of Pathogenesis and Drug Effects in Tuberculosis (Deadline: 20 December 2024)
• Molecular Advances and Perspectives in Multiple Sclerosis (Deadline: 20 December 2024)
• The Role of Estrogen Receptors in Health and Diseases (Deadline: 20 December 2024)
• Inflammation in Atherosclerosis: Current Advances (Deadline: 20 December 2024)
• Paroxysmal Nocturnal Hemoglobinuria: Pathophysiology and Novel Therapeutic Approaches (Deadline: 20 December 2024)
• Amyloid Hetero-Aggregation: 2nd Edition (Deadline: 20 December 2024)
• Advances In and Insights into the Treatment of Glaucoma (Deadline: 20 December 2024)
• Molecular Research in Viral Hepatitis and Liver Cancer (Deadline: 20 December 2024)
• Molecular Mechanisms of Viral Infection in Pregnancy (Deadline: 20 December 2024)
• Cytokine Signaling in Development, Homeostasis and Disease (Deadline: 20 December 2024)
• The Impact of Sex Hormones on Cardiovascular System: Pathophysiological Perspective (Deadline: 20 December 2024)
• Immune Evasion and Pathological Prognostic Biomarkers in Bladder Cancer (Deadline: 20 December 2024)
• Pulmonary Hypertension: Pre-clinical Research on New Molecular Targets and Therapeutic Strategies (Deadline: 20 December 2024)
• Molecular and Cellular Research on the Glioma and Tumor Microenvironment (Deadline: 20 December 2024)
• Oral and Dental Infectious Diseases: Molecular Pathology, Diagnosis and Therapy (Deadline: 20 December 2024)
• Adipose Tissue Dynamics in Laminopathies (Deadline: 20 December 2024)
• Molecular Insights into Metabolic Pathways and Age-Related Pathologies (Deadline: 20 December 2024)
• Innovative Therapeutic Approaches in Neuropsychiatric Disorders (Deadline: 20 December 2024)
• Molecular Research on Amyloidosis in Pathobiology and Therapy (Deadline: 20 December 2024)
• Recent Advances on Multi-Target Directed Ligands (Deadline: 20 December 2024)
• Towards an Understanding of Retinal Diseases and Novel Treatment: 3rd Edition (Deadline: 20 December 2024)
• Molecular Insights into Muscular Dystrophy (Deadline: 20 December 2024)
• Coronavirus Disease (COVID-19): Pathophysiology 5.0 (Deadline: 20 December 2024)
• Liver Diseases: From Molecular Basis to Potential Therapy (Deadline: 20 December 2024)
• Advances in Anti-Aging Treatment Development, 2nd Edition (Deadline: 20 December 2024)
• Type 1 Diabetes: Cellular and Molecular Pathophysiology (Deadline: 20 December 2024)
• Epigenetic Biomarkers—Technologies and Applications in Complex Disease Diagnostics and Beyond (Deadline: 20 December 2024)
• Diabetes and Its Complications: From Molecular Mechanisms to Novel Therapeutic Approaches (Deadline: 20 December 2024)
• Aging and Chronic Kidney Disease (Deadline: 20 December 2024)
• Advances in Molecular Research of Diabetic Cardiomyopathy (Deadline: 20 December 2024)
• Osteoporosis: From Molecular Mechanisms to Therapies 4.0 (Deadline: 20 December 2024)
• Biomarkers in Rare Diseases 3.0 (Deadline: 20 December 2024)
• Molecular Insights into Lipodystrophy (Deadline: 20 December 2024)
• COVID-19: Advances in Pathophysiology and Therapeutics (Deadline: 20 December 2024)
• Molecular Advances in Blood–Brain Barrier, Blood–Cerebrospinal Fluid Barrier and Cerebrospinal Fluid–Brain Barriers (Deadline: 20 December 2024)
• Molecular Mechanisms of Atherosclerosis (Deadline: 20 December 2024)
• Molecular Advances in Periodontitis Diagnosis and Treatment (Deadline: 20 December 2024)
• Therapeutic Potential of Antioxidants in the Prevention of Human Diseases (Deadline: 20 December 2024)
• Molecular Mechanism in Multiple Sclerosis and Related Disorders: 2nd Edition (Deadline: 20 December 2024)
• Schizophrenia: From Molecular Mechanism to Therapy (Deadline: 20 December 2024)
• Advances in Lung Inflammation, Injury, and Repair (Deadline: 20 December 2024)
• Vitamins: Molecular Mechanisms and Biological Function (Deadline: 20 December 2024)
• Recent Advances in Photobiomodulation Therapy (PBMT) (Deadline: 20 December 2024)
• Multifaceted World of Chemically Modified Oligonucleotides for Nucleic Acid Therapeutics (Deadline: 20 December 2024)
• Molecular Research on Embryo Developmental Potential (Deadline: 20 December 2024)
• Molecular Mechanisms in Dry Eye Disease: Effects on Pathogenesis, Treatment and Ocular Surgery (Deadline: 20 December 2024)
• The Role of Natural and Synthetic Sulfur Compounds in Human Health and Diseases (Deadline: 20 December 2024)
• Role of Epigenetics in Degenerative and Inflammatory Rheumatic Diseases (Deadline: 20 December 2024)
• Immunoregulation Within the Tumor Microenvironment: Special Emphasis on Macrophages and NK Cells (Deadline: 20 December 2024)
• Aquaporins in Brain Disease 2.0 (Deadline: 20 December 2024)
• Molecular Physiological and Pathological Progression of Neurological Diseases (Deadline: 20 December 2024)
• Molecular Mechanisms and Targeted Therapies of Breast Cancer (Deadline: 20 December 2024)
• Cardiovascular Diseases: Histopathological and Molecular Diagnostics (Deadline: 20 December 2024)
• Fractalkine (CX3CL1) and Its Chemoattractant and Adhesion Molecule Properties in Health and Disease (Deadline: 20 December 2024)
• Molecular Genetics of Human Leucocyte Antigen in Diseases (Deadline: 20 December 2024)
• Zebrafish as a Model in Human Disease: 3rd Edition (Deadline: 20 December 2024)
• Therapeutic Targets and Approaches to Manage Inflammation: Disappointing Past, Current Efforts and Faint Hopes (Deadline: 20 December 2024)
• Acute Radiation Syndrome and Therapies after Combined Radiation Injury (Deadline: 20 December 2024)
• Molecular Targeted Therapies and Precision Medicine for Malignant Diseases (Deadline: 20 December 2024)
• The Role of Red Blood Cell Hemodynamic Functionality in Health and Disease (Deadline: 20 December 2024)
• Acute Kidney Injury: From Molecular Pathology to Therapies (Deadline: 20 December 2024)
• Molecular Mechanisms and Therapeutic Advances in Metastatic Brain Tumours (Deadline: 20 December 2024)
• Research of Pathogenesis and Novel Therapeutics in Arthritis: 4th Edition (Deadline: 21 December 2024)
• Metabolism in Neurological Disorders: New Molecular Perspectives (Deadline: 25 December 2024)
• Molecular Pathology and Diagnosis of Endometriosis (Deadline: 28 December 2024)
• Molecular Advances in Neurologic and Neurodegenerative Disorders (Deadline: 28 December 2024)
• Molecular Pathology and Treatment of Spinal Cord Injury (Deadline: 30 December 2024)
• Machine Learning in Disease Diagnosis and Treatment (Deadline: 30 December 2024)
• Hepatitis C Virus: Pathogenetic Mechanisms, Residual Problems after Cure and Hopes for Elimination (Deadline: 30 December 2024)
• Rheumatic Diseases: Molecular Mechanisms and Treatment (Deadline: 30 December 2024)
• Molecular Biology in Forensic Science: Past, Present and Future, 2nd Edition (Deadline: 30 December 2024)
• Lipoprotein(a) and Cardiovascular Diseases (Deadline: 30 December 2024)
• Cardiovascular Diseases—a Focus on Atherosclerosis, Its Prophylaxis, Complications and Recent Advancements in Therapies 2.0 (Deadline: 30 December 2024)
• Mechanisms of Diabetic Cardiomyopathy (Deadline: 30 December 2024)
• Role of Calprotectin in Human Health and Disease (Deadline: 30 December 2024)
• Understanding the Role of Non-coding DNA in Neurodegenerative Disease (Deadline: 30 December 2024)
• Current Advances in Hereditary Renal Diseases and Cancers (Deadline: 30 December 2024)
• Retinal Diseases: From Molecular Pathology to Therapies—2nd Edition (Deadline: 30 December 2024)
• Innovative Molecular Target and Therapeutic Approaches in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) 4.0 (Deadline: 30 December 2024)
• Diabetes: Molecular Mechanisms and Treatment (Deadline: 30 December 2024)
• Molecular Insights into Migraines (Deadline: 30 December 2024)
• Molecular Mechanisms of Cancer Invasion and Metastasis (Deadline: 30 December 2024)
• Chronic Obstructive Pulmonary Disease (COPD): From Pathogenesis to Therapy (Deadline: 30 December 2024)
• Intermediate Melanocytic Lesions (Deadline: 30 December 2024)
• Molecular and Translational Research on Bone Tumors, 2nd Edition (Deadline: 30 December 2024)
• Myotonic Dystrophies: An Update on Pathology, Molecular Pathogenesis and Therapeutic Approaches (Deadline: 30 December 2024)
• The Role of Antithrombin in Blood Disorders (Deadline: 30 December 2024)
• New Trends and Challenges in Chronic Diseases (Deadline: 30 December 2024)
• Advances in the Treatment of Acute and Chronic Pain (Deadline: 30 December 2024)
• The Endothelial Glycocalyx: Physiological, Pathological and Therapeutic “Holy Grail” (Deadline: 31 December 2024)
• Molecular Studies of Refractive Error (Deadline: 31 December 2024)
• Myocardial Disease: Molecular Pathology and Treatments (Deadline: 31 December 2024)
• Cellular and Molecular Mechanisms of Acute Lung Injury (Deadline: 31 December 2024)
• Targeting Non-coding RNAs for the Development of Cancer Therapeutic Approaches (Deadline: 31 December 2024)
• Novel Diagnostic and Preventive Options of Pregnancy Complications Originated from Placental Pathologies (Deadline: 31 December 2024)
• Coumarins as Effective Therapeutic Agents: Mechanism of Action and Diverse Activity (Deadline: 31 December 2024)
• Diabetic Bone Disease: New Insights into Molecular Mechanisms and Therapeutic Approaches (Deadline: 31 December 2024)
• Pathophysiological and Molecular Insights into Heart Failure: From Diagnosis to Therapy (Deadline: 31 December 2024)
• Molecular Mechanisms of Bone Development and Differentiation in Health and Disease (Deadline: 31 December 2024)
• Advances in Understanding Molecular Mechanisms Involved in Chronic Kidney Injury and Repair (Deadline: 31 December 2024)
• Metabolic Dysfunction-Associated Steatotic Liver Disease: From Basic Research to Clinical Approaches (Deadline: 31 December 2024)
• Exploring Molecular Mechanisms of Inflammatory Diseases (Deadline: 31 December 2024)
• Periodontal Disease: From Pathogenesis, Diagnosis to Treatment (Deadline: 31 December 2024)
• Molecular Advances in Gut Microbiota and Intestinal Diseases (Deadline: 31 December 2024)
• New Advances in Cystinosis from Basic to Clinical Research (Deadline: 31 December 2024)
• Breast Cancer: From Pathophysiology to Novel Therapies (Deadline: 31 December 2024)
• Hepatopancreatic and Intestine Diseases: From Molecular Basis to Therapy (Deadline: 31 December 2024)
• Molecular Research on Systemic Sclerosis: From Pathogenesis to Management (Deadline: 31 December 2024)
• Molecular Insight into Retinal Diseases (Deadline: 31 December 2024)
• Cardiac Repair and Regeneration: From Pathogenesis to Therapeutic Perspectives (Deadline: 31 December 2024)
• Molecular and Cellular Mechanisms of Intervertebral Disc Disease (Deadline: 31 December 2024)
• Breakthroughs in Cardiac Tissue Remodeling: From Mechanisms to Therapeutics (Deadline: 31 December 2024)
• Cellular and Molecular Mechanisms in Lung Health and Disease (Deadline: 31 December 2024)
• Molecular Insight into Skin Infection and Inflammation (Deadline: 31 December 2024)
• New Discoveries in Cartilage Biology (Deadline: 31 December 2024)
• Recent Advances in Human Papillomavirus (HPV) Research (Deadline: 31 December 2024)
• Research Advances in Retinal Neurodegeneration and Neuroprotection Strategies (Deadline: 31 December 2024)
• Molecular Targets in Gastrointestinal Diseases (Deadline: 31 December 2024)
• Endothelial Dysfunction and Cardiovascular Diseases (Deadline: 31 December 2024)
• Antimicrobial Peptides in Preterm Birth (Deadline: 31 December 2024)
• Essential Metals in Neurological Diseases and Cancer (Deadline: 31 December 2024)
• Inflammatory Bowel Disease: Focus on Molecular Research (Deadline: 31 December 2024)
• Regulation Mechanism of Osteoblast/Osteoclast Differentiation (Deadline: 31 December 2024)
• The Pathogenesis of Alcohol-Associated Hepatitis and Its Therapies (Deadline: 31 December 2024)
• Nonalcoholic Liver Disease: Mechanisms, Prevention, and Treatment (Deadline: 31 December 2024)
• New Advances in Inflammation and Repair in Respiratory Diseases (Deadline: 31 December 2024)
• Anticancer Medicine and Cancer Immunotherapy (Deadline: 31 December 2024)
• Recent Advancements in Organ Transplantation: From Organ Protection to Molecular Therapy (Deadline: 31 December 2024)
• A Commemorative Issue in Honor of Professor Peter A. Ward: World Expert in Sepsis (Deadline: 31 December 2024)
• Molecular Mechanisms for Skin Protection and Aging (Deadline: 31 December 2024)
• Molecular Mechanisms and New Therapies for Breast Cancer (Deadline: 31 December 2024)
• Beyond Silos: A Comprehensive Understanding of HIV Functional Cure and NeuroHIV (Deadline: 31 December 2024)
• Genetic and Molecular Mechanisms of Obesity (Deadline: 31 December 2024)
• Radiosensitizers in the Service of Radiotherapy: Drug Design, Development and Therapy (Deadline: 31 December 2024)
• MicroRNAs in the Pathophysiology of Chronic Diseases: 2nd Edition (Deadline: 31 December 2024)
• Novel Insights into Molecular Mechanisms of Pulmonary Pathology (Deadline: 31 December 2024)
• Gaucher Disease: From Molecular Mechanisms to Treatments (Deadline: 31 December 2024)
• Adapter CAR T Cells: From the Idea to the Clinic (Deadline: 31 December 2024)
• Signaling Pathways and Novel Therapies in Heart Disease (Deadline: 31 December 2024)
• Molecular Diagnostics and Therapeutics of Epileptic Neurodevelopment (Deadline: 31 December 2024)
• Complications of Type 1 Diabetes in Pediatric Age: Early Biomarkers and New Insights into Diagnosis and Prevention Strategies (Deadline: 15 January 2025)
• Molecular Mechanisms and Therapies for Metabolic-Associated Fatty Liver Diseases (Deadline: 15 January 2025)
• Molecular Mechanism of Acute Myeloid Leukemia (Deadline: 15 January 2025)
• Biomarkers for Cardiovascular Risk Prediction (Deadline: 18 January 2025)
• Advances in Neurodegenerative Diseases and Inflammation: Pathogenesis, Biomarkers and Treatments (Deadline: 20 January 2025)
• Molecular Insight into Dentistry and Craniofacial Surgery: Celebrating the 110th Anniversary of Dentistry in Italy (Deadline: 20 January 2025)
• Application of Natural Products in Prevention of Bone Related Diseases (Deadline: 20 January 2025)
• Male Genitourinary Tumors: Molecular Mechanisms and Potential Therapeutic Targets (Deadline: 20 January 2025)
• New Biological and Immunological Approaches to Cancer Therapy (Deadline: 20 January 2025)
• How Melanin Affects the Therapy Response of Cutaneous Melanoma? (Deadline: 20 January 2025)
• Hormone Replacement Therapy (Deadline: 20 January 2025)
• Advances in Skin Cancer Pathology: From Pathogenesis to Precision Therapies (Deadline: 20 January 2025)
• Molecular Advances in Muscular Dystrophy (Deadline: 20 January 2025)
• Molecular Landscape of Cutaneous Wound Healing in Health and Disease (Deadline: 20 January 2025)
• Molecular Regulatory Mechanisms of Non-coding RNA in Cardiovascular Disease (Deadline: 20 January 2025)
• Therapeutic Uses of Adult Stem Cells (Deadline: 20 January 2025)
• Probing the Role of Metabolomics to Unveil the Molecular Landscape of Cardiovascular Diseases (Deadline: 20 January 2025)
• Molecular Mechanisms of Retinal Diseases: An Update (Deadline: 20 January 2025)
• Molecular Pathology Research on Blood Tumors (Deadline: 20 January 2025)
• Muscle Atrophy: From Bench to Bedside 2.0 (Deadline: 20 January 2025)
• Advanced Research of Skin Inflammation and Related Diseases (Deadline: 20 January 2025)
• Molecular Mechanisms and Treatments of Organ Hypoxia or Ischemia (Deadline: 20 January 2025)
• Latest Updates about Interstitial Lung Disease (Deadline: 20 January 2025)
• Current Research for Heart Disease Biology and Therapeutics: 2nd Edition (Deadline: 20 January 2025)
• Molecular Insights in Hepatological Complications (Deadline: 20 January 2025)
• Antiphospholipid Syndrome: From Pathophysiology to Therapy (Deadline: 20 January 2025)
• Cellular and Molecular Mechanisms of Cardiovascular Repair (Deadline: 20 January 2025)
• Smooth Muscle Cells in Vascular Disease (Deadline: 20 January 2025)
• Cardiovascular Disease: Molecular Basis, Potential Therapeutic Targets and Translational Research (Deadline: 20 January 2025)
• New Breakthroughs in Molecular Diagnostic Tools for Human Diseases (Deadline: 20 January 2025)
• New Insights into Liver Biology and Disease Pathogenesis: Shedding Light on Novel Diagnostic and Therapeutic Approaches (Deadline: 20 January 2025)
• Molecular Advances in Haematological Malignancies (Deadline: 20 January 2025)
• Anemia and Iron Metabolism: Laboratory Diagnosis, Novel Biomarkers and Environmental Influence (Deadline: 20 January 2025)
• Molecular Mediators of Exercise: Cross-Organ Communication Promoting Health and Combating Disease (Deadline: 20 January 2025)
• Molecular Advances in Obstetrical and Gynaecological Disorders (Deadline: 20 January 2025)
• Molecular Precision Medicine: Unraveling Novel Mechanisms and Delivery Strategies in Complex Diseases (Deadline: 20 January 2025)
• Depression: Molecular Pathology and Modern Therapy (Deadline: 20 January 2025)
• Vascular Changes in Systemic Degenerative Diseases and Their Pathological Implications: Molecular Biological Insights (Deadline: 20 January 2025)
• Chronic Lymphocytic Leukemia: Molecular Pathologies and Therapeutic Strategies (Deadline: 20 January 2025)
• Molecular and Cellular Mechanisms and the Pathophysiology of Skeletal Muscle Diseases (Deadline: 20 January 2025)
• New Insights into the Use of Mouse Models for the Study of Skin Disorders (Deadline: 20 January 2025)
• Molecular Diagnosis and Treatments of Diabetes Mellitus (Deadline: 20 January 2025)
• Inflammatory Bowel Disease’s Journey: From Metabolism and Immunity to New Therapeutic Horizons (Deadline: 20 January 2025)
• Novel Therapies for Schizophrenia: Beyond Dopamine (Deadline: 20 January 2025)
• Genetic Bases of Neurodegenerative Disease (Deadline: 20 January 2025)
• Molecular Mechanisms and Biomarkers for Appropriate Diagnosis and Therapeutic Strategy in Organ Dysfunction (Deadline: 20 January 2025)
• Renin-Angiotensin System in Health and Diseases (Deadline: 20 January 2025)
• The Epigenetic Landscape in Cancer (Deadline: 20 January 2025)
• Vitamin D Signaling in Human Health and Diseases (Deadline: 20 January 2025)
• Recent Molecular Research in Virology and Oncology (Deadline: 20 January 2025)
• Recent Advances in Gluten-Related Disorders (Deadline: 20 January 2025)
• Diabetes-Related Cognitive Impairment Diseases (Deadline: 20 January 2025)
• Pulmonary Arterial Hypertension: From Molecular Mechanisms to Novel Therapeutic Approaches (Deadline: 20 January 2025)
• Molecular Insights into Hair Regeneration (Deadline: 20 January 2025)
• Molecular Pathophysiology of Lung Diseases (Deadline: 20 January 2025)
• Molecular Advances in Lung Diseases 2.0 (Deadline: 20 January 2025)
• Rare Diseases and Neuroscience (Deadline: 20 January 2025)
• Cytokines: From Cancer to Autoimmunity: 2nd Edition (Deadline: 20 January 2025)
• Mesenchymal Stem Cells Differentiation in Health and Disease (Deadline: 20 January 2025)
• From Bench to Bedside: Well-Established and Emerging Preclinical Models in Cardiovascular Research (Deadline: 20 January 2025)
• New Insights into CKD and Age-Related Bone and Mineral Disorders (Deadline: 20 January 2025)
• Molecular and Genetic Studies on Tourette Syndrome and Comorbid Disorders (Deadline: 20 January 2025)
• New Biomarkers and Therapy for Cancer Stem Cells (Deadline: 20 January 2025)
• Cutting-Edge Research and Applications of Extracellular Microvesicles in Disease Management (Deadline: 20 January 2025)
• The Role of Oxidative Stress in Human and Animal Health (Deadline: 20 January 2025)
• Genetics, Genomics and Molecular Pathogenesis of Myocardial Diseases (Deadline: 20 January 2025)
• Identification of New Molecular Subgroups in Breast Cancer (Deadline: 20 January 2025)
• New Molecular Insights into Scar and Wounds (Deadline: 20 January 2025)
• Chronic Pain and Fibromyalgia: Biomarkers and Pathophysiology (Deadline: 20 January 2025)
• Molecular Mechanisms and Therapies of Chronic Obstructive Pulmonary Disease (Deadline: 20 January 2025)
• Exploring the Therapeutic Potential of Modulators of Regulated Cell Death for Retinal Atrophy (Deadline: 20 January 2025)
• Lung Diseases and Lung Transplantations: Molecular Pathogenesis and Advanced Therapies (Deadline: 20 January 2025)
• Molecular Research and Treatment of Oral Diseases (Deadline: 20 January 2025)
• Hepatocellular Carcinoma in 2023: What Is New on Pathogenesis, Diagnosis and Treatment (Deadline: 20 January 2025)
• Pathogenesis and Novel Therapeutic Approaches for Sarcomas (Deadline: 20 January 2025)
• Molecular Mechanisms of Retinal Degeneration and How to Avoid It—2nd Edition (Deadline: 20 January 2025)
• Non-coding RNAs' Functionality-Diagnosis and Therapy in Cancer and Other Indications (Deadline: 20 January 2025)
• Recent Developments and Updates in Acute Lymphoblastic Leukemia (Deadline: 20 January 2025)
• Molecular Pathogenesis and Therapeutics in Retinopathy (Deadline: 20 January 2025)
• Glaucoma: Diagnostics and Therapeutic Perspectives (Deadline: 20 January 2025)
• Hallmarks of Cancer: Emerging Insights and Innovations (Deadline: 25 January 2025)
• Molecular Pathology in Breast and Mammary Cancers (Deadline: 26 January 2025)
• Molecular Pathology and Diagnosis of Neurodegenerative Disorders (Deadline: 26 January 2025)
• Molecular Mechanisms and Signalling Pathways in Cardiovascular Pathophysiology (Deadline: 30 January 2025)
• Innovative Strategies to Target Metabolism, Inflammation, and Oxidative Stress in Human Diseases (Deadline: 30 January 2025)
• Interplay of Metabolism and Inflammation in Gastrointestinal Disease (Deadline: 30 January 2025)
• Endothelial Dysfunction: From Molecular Pathologies to Therapeutic Strategies (Deadline: 30 January 2025)
• Mast Cell Disorders: From Molecular Mechanisms to Therapeutic Approaches (Deadline: 30 January 2025)
• From Kidney Disease to Hypertension: Molecular Basis and Pathophysiology (Deadline: 30 January 2025)
• Molecular Mechanisms and Pathophysiology of Cystic Fibrosis (Deadline: 30 January 2025)
• Translating Molecular Psychiatry: From Biomarkers to Personalized Therapies (Deadline: 31 January 2025)
• New Trends in Diabetes, Hypertension and Cardiovascular Diseases: 3rd Edition (Deadline: 31 January 2025)
• Pathophysiology and New Therapies of Alopecia (Deadline: 31 January 2025)
• Molecular Pathologies and Treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (Deadline: 31 January 2025)
• Innovative Molecular Diagnostic and Therapeutic Strategies for Biofilm-Associated Periprosthetic Joint Infections (Deadline: 31 January 2025)
• Molecular Mechanisms: New Insights into the Pathogenesis of Neonatal Disorders (Deadline: 31 January 2025)
• Molecular Mechanisms, Pathophysiology and Therapeutic Strategies of Chronic Obstructive Pulmonary Disease (COPD) (Deadline: 31 January 2025)
• Cluster Headache: From Pathogenesis to Future Treatment Perspectives (Deadline: 31 January 2025)
• Sleep and Pain: From Bench to Bedside (Deadline: 31 January 2025)
• New Biomarkers in Pancreatic Diseases (Deadline: 31 January 2025)
• Rare Diseases Associated with Short Stature: Genetics, Pathogenesis and Therapy (Deadline: 31 January 2025)
• Lung and Liver Fibrotic Diseases (Deadline: 31 January 2025)
• Stroke: Novel Molecular Mechanisms and Therapeutic Approaches (Deadline: 31 January 2025)
• Humidification Approaches to Molecular and Morpho-Pathology Epithelial Airway Cell Injury in Mechanically Ventilated Patients (Deadline: 31 January 2025)
• Molecular and Cellular Aspects of Breast Cancer Metastasis (Deadline: 31 January 2025)
• Inflammatory Bowel Disease and Microbiome (Deadline: 31 January 2025)
• Rheumatoid Arthritis: From Molecular Basis to Therapies (Deadline: 31 January 2025)
• Molecular Mechanism and Therapy of Psoriasis (Deadline: 31 January 2025)
• Insights into Mitochondrial Iron Metabolism: Connections to Cancer and Other Pathologies (Deadline: 31 January 2025)
• Health-Promoting Effects of Food Legumes and Their Molecular Mechanisms (Deadline: 31 January 2025)
• Animal Models for the Study of Human Health and Diseases (Deadline: 31 January 2025)
• Oxidative Stress and Inflammation in Health and Disease (Deadline: 31 January 2025)
• Molecular Precision Medicine: Unraveling Disease Mechanisms, Targeted Therapeutics and Innovative Diagnostics (Deadline: 31 January 2025)
• Recent Research on Hypertension and Related Complications (Deadline: 31 January 2025)
• Molecular Research of Cancer Metabolism and Biomarkers (Deadline: 31 January 2025)
• Fibrotic Disease: From Pathophysiology to Treatment (Deadline: 31 January 2025)
• Endocannabinoids, Cannabinoids and Psychiatry: Biological Mechanisms—3rd Edition (Deadline: 31 January 2025)
• Molecular Mechanisms of Heart Failure: Insights and Therapeutic Strategies (Deadline: 31 January 2025)
• Hemophilia: From Pathophysiology to Novel Therapies (Deadline: 31 January 2025)
• New Molecular Insights and Therapeutic Strategies for Ocular Vascular Pathologies (Deadline: 31 January 2025)
• Protein–RNA Interactions: Function, Mechanism, and Identification (Deadline: 20 February 2025)
• Molecular Research on Skeletal Muscle Diseases (Deadline: 20 February 2025)
• Splice-Switching Antisense Oligonucleotides: 30 Years after Advocating Exon-Skipping Therapy for Duchenne Muscular Dystrophy (Deadline: 20 February 2025)
• Molecular Research of Microbial Infection and Phage Therapy (Deadline: 20 February 2025)
• Natural Products in Lifestyle-Related Diseases: Molecular Mechanisms, Prevention and Treatments (Deadline: 20 February 2025)
• Molecular Pathways and Therapeutic Strategies for Fibrotic Conditions (Deadline: 20 February 2025)
• MicroRNA Regulation in Human Health and Diseases (Deadline: 20 February 2025)
• Bone Tissue Engineering: Opportunities and Challenges (Deadline: 20 February 2025)
• The Role of Nuclear Medicine in Cancer Diagnosis and Therapy (Deadline: 20 February 2025)
• Understanding the Mechanisms of Mitochondrial Stress and Its Association with Human Diseases (Deadline: 20 February 2025)
• Molecular Aspects of Photodynamic Therapy (Deadline: 20 February 2025)
• Pathology of Gliomas (Deadline: 20 February 2025)
• Recent Research on Cell and Molecular Biology (Deadline: 20 February 2025)
• Molecular Advances and Insights into Liver Diseases (Deadline: 20 February 2025)
• Molecular Mechanisms of Pain and Analgesia (Deadline: 20 February 2025)
• Recent Advances in Skin Disease and Comorbidities 2.0 (Deadline: 20 February 2025)
• Molecular Mechanisms of Tendinopathy: Unraveling the Pathogenesis of Tendon Diseases (Deadline: 20 February 2025)
• Biomaterials for Wound Healing and Tissue Regeneration (Deadline: 20 February 2025)
• Hormone Receptors and Signaling in Breast Cancer (Deadline: 20 February 2025)
• The Role of Astrocytes in Human Diseases (Deadline: 20 February 2025)
• Molecular Research on Adenosine Receptors: From Cell Biology to Human Diseases (Deadline: 20 February 2025)
• Molecular Mechanisms and Therapy of Cardiomyopathy (Deadline: 20 February 2025)
• Recent Advances in Prevention, Diagnosis and Treatment of Pediatric Diseases (Deadline: 20 February 2025)
• Understanding Sepsis: Pathophysiology, Diagnostics and Early Intervention (Deadline: 20 February 2025)
• Molecular Research of Biomedical X-ray Fluorescence Imaging (XFI) (Deadline: 20 February 2025)
• Cellular and Molecular Biology in the Compromised Neonate (Deadline: 20 February 2025)
• Challenges and Advances of Therapeutic Approaches in Human Diseases: Focus on Stem Cell Therapies (Deadline: 20 February 2025)
• Molecular Pathology and Molecular Pharmacology of Chronic Pain (Deadline: 20 February 2025)
• Vasculitis: From Molecular Biology to Therapy (Deadline: 20 February 2025)
• Omics Sciences for Salivary Diagnostics—2nd Edition (Deadline: 20 February 2025)
• Molecular Research on Pharmacogenetics (Deadline: 20 February 2025)
• Molecular Insight into Zoonotic Infections (Deadline: 20 February 2025)
• Eosinophilic Esophagitis: Molecular Mechanisms, Diagnosis, and Therapeutic Strategies (Deadline: 20 February 2025)
• Endothelial Dysfunction: Molecular Mechanisms and Therapeutic Strategies (Deadline: 20 February 2025)
• An Update for Photodynamic Therapy as a Versatile Tool for Biological Breakthroughs (Deadline: 20 February 2025)
• Molecular Insights into Infectious Diseases (Deadline: 20 February 2025)
• Molecular Insights in Hepatic Disease and Hepatocellular Carcinoma (Deadline: 20 February 2025)
• Purinergic Signalling in Physiology and Pathophysiology 2.0 (Deadline: 20 February 2025)
• Aquatic Organisms Models Dedicated to Disease (Deadline: 20 February 2025)
• Etiology and Pathogenesis of Pulpitis and Apical Periodontitis 2023 (Deadline: 20 February 2025)
• Molecular Advances in Glomerular Diseases (Deadline: 20 February 2025)
• CDKL5 Deficiency Disorders: From Molecular Mechanisms to Therapeutics (Deadline: 20 February 2025)
• Chronic Pain: Diagnosis, Pathophysiological Mechanisms and Treatment (Deadline: 20 February 2025)
• Advanced Molecular Research in Benign and Malignant Lung Disease (Deadline: 20 February 2025)
• Advanced Science in Alzheimer’s Disease (Deadline: 20 February 2025)
• Molecular Insights into Thrombosis (Deadline: 20 February 2025)
• Heart-Brain Interaction: Atrial Fibrillation and Stroke (Deadline: 20 February 2025)
• Latest Progress in Messenger RNA Therapeutics (Deadline: 20 February 2025)
• Cardiovascular Disease: Molecular Advances on Pathophysiology and Therapies (Deadline: 20 February 2025)
• Novel Advances on Systemic Lupus Erythematosus and Antiphospholipid Syndrome (Deadline: 20 February 2025)
• Role of Proteomics in Human Diseases and Infections (Deadline: 20 February 2025)
• The Role of Heat Shock Proteins: From Molecular Mechanisms to Therapeutics 2.0 (Deadline: 20 February 2025)
• Genetic and Metabolic Molecular Research of Lysosomal Storage Disease 4.0 (Deadline: 20 February 2025)
• Osteoarthritis: From Molecular Mechanism to Novel Therapy (Deadline: 20 February 2025)
• Kidney Diseases: Molecular Pathogenesis and Therapeutic Strategies—2nd Edition (Deadline: 20 February 2025)
• Recent Research of DNA Repair and Damage in Human Health (Deadline: 20 February 2025)
• The Role of Extracellular Vesicles in Inflammatory Diseases (Deadline: 20 February 2025)
• Metabolic Dysfunction-Associated Steatotic Liver Disease: From Basic Science to Therapy (Deadline: 20 February 2025)
• Molecular Research in Triple-Negative Breast Cancer (Deadline: 20 February 2025)
• Signalling Pathway and Regulation of Oxidative Stress in Lung Diseases (Deadline: 20 February 2025)
• Novel Therapeutic Approaches for Migraine Headaches (Deadline: 20 February 2025)
• Molecular Basis and Treatment of Skin Diseases and Their Associated Complications (Deadline: 20 February 2025)
• Advances in Molecular Mechanisms of Kidney Disease: Integrating Renal Tumorigenesis (Deadline: 20 February 2025)
• Cardioprotection in Drug-Induced Cardiotoxicity (Deadline: 20 February 2025)
• Multidrug Resistance in Cancer: Molecular Mechanisms and Therapeutic Implications (Deadline: 20 February 2025)
• Cardiovascular Diseases: Aging and Other Risk Factors (Deadline: 20 February 2025)
• Advances in Pathogenesis, Molecular Mechanisms, and Therapeutic Strategies for Neurodegenerative Diseases (Deadline: 20 February 2025)
• Skin, Autoimmunity and Inflammation 2.0 (Deadline: 20 February 2025)
• Advanced Therapies for Inherited Diseases and Cancer: Recent Progress (Deadline: 20 February 2025)
• Advanced Molecular Insights into Renal Disorders (Deadline: 20 February 2025)
• Molecular Research of Endocytic and Autophagic Pathways in Diseases (Deadline: 20 February 2025)
• Pathogenesis of Pregnancy-Related Complication 2024 (Deadline: 20 February 2025)
• New Therapies for Acute Myeloid Leukemia (Deadline: 20 February 2025)
• Molecular Pathology, Diagnostics, and Therapeutics of Kidney Disease (Deadline: 20 February 2025)
• Oxidative Stress and Mitochondrial Dysfunction (Deadline: 20 February 2025)
• Growth Hormone and Human Disease (Deadline: 20 February 2025)
• Inflammatory Bowel Disease: Molecular Insights (Deadline: 20 February 2025)
• New Insights into Autophagy and Retinal Degeneration (Deadline: 25 February 2025)
• Metabolic Dysfunction in Steatotic Liver Disease: Molecular Mechanisms and Therapeutic Approaches (Deadline: 25 February 2025)
• Molecular Role of Lipids and Lipoproteins in Vascular Disease (Deadline: 25 February 2025)
• Molecular Insights and Current Challenges Driving Advances in Plasma Medicine (Deadline: 25 February 2025)
• New Insights into Anticancer Strategies (Deadline: 25 February 2025)
• Molecular Basis and Latest Therapeutic Strategies for Genetic Diseases in Children (Deadline: 26 February 2025)
• Diabetes: Advances of Molecular Research (Deadline: 26 February 2025)
• The Role of the Mitochondria in Human Health and Diseases (Deadline: 28 February 2025)
• Advances in Molecular Understanding of Ocular Adnexal Disease, 2nd Edition (Deadline: 28 February 2025)
• Inflammation and Metabolic Response in Mitochondrial Diseases (Deadline: 28 February 2025)
• Molecular Mechanisms and Treatments of Myocardial Infarction (Deadline: 28 February 2025)
• The Role of Oxidative Stress and Antioxidants in Human Disease (Deadline: 28 February 2025)
• Advanced Molecular Research on the Diagnosis and Treatment of Chronic Liver Diseases (Deadline: 28 February 2025)
• Mechanism(s) of HFpEF and HFrEF (Deadline: 28 February 2025)
• Interplay between the Human Microbiome and Diseases (Deadline: 28 February 2025)
• Non-Coding RNA: Biomarkers for Cardiovascular Diseases (Deadline: 28 February 2025)
• Molecular Research on Skin Inflammation (Deadline: 28 February 2025)
• Pathogenesis of Preeclampsia: From a Molecular Perspective (Deadline: 28 February 2025)
• Musculoskeletal Diseases: Inflammation, Degeneration or Mechanical Stress (Deadline: 28 February 2025)
• Endothelial Function and Cardiovascular Disease: Molecular Advances and Challenges (Deadline: 28 February 2025)
• New Insights into Kidney Disease: Physiopathology, Molecular Diagnostics, and Therapy (Deadline: 28 February 2025)
• The Role of Membrane Proteins in Neurological Diseases (Deadline: 28 February 2025)
• Molecular Therapeutic Strategies in Allergic Diseases (Deadline: 28 February 2025)
• Molecular Diagnostics and Treatment Advances in Lung Diseases (Deadline: 28 February 2025)
• Mitochondrial Function in Health and Diseases (Deadline: 28 February 2025)
• New Insights into Hyaluronan in Human Medicine (Deadline: 28 February 2025)
• Molecular Advances in Combinatorial Therapies for Spinal Cord Injury (Deadline: 28 February 2025)
• The Role of Long Non-Coding RNAs in Stress and Diseases (Deadline: 28 February 2025)
• New Advances in the Field of Thrombosis and Hemostasis (Deadline: 28 February 2025)
• Recent Advances in RNA Drug Development (Deadline: 28 February 2025)
• Cellular Metabolism and Retinal Diseases: Unraveling Molecular Pathways and Therapeutic Targets (Deadline: 28 February 2025)
• Human Induced Pluripotent Stem Cells in Disease Modeling and Cell-Based Therapies—Challenges and Perspectives (Deadline: 28 February 2025)
• Molecular Mechanisms of Sjögren's Syndrome, 4th Edition (Deadline: 28 February 2025)
• Advances in Osteogenesis (Deadline: 28 February 2025)
• Molecular Research and Targeted Therapy of Lung Cancer (Deadline: 28 February 2025)
• Ferroptosis Mechanisms and Bone Diseases (Deadline: 28 February 2025)
• The Molecular Basis of Vascular Pathology (Deadline: 28 February 2025)
• C. elegans as a Disease Model: Molecular Perspectives: 2nd Edition (Deadline: 28 February 2025)
• Cancer Immunotherapy Biomarkers (Deadline: 28 February 2025)
• Role and Application of Stem Cells in Regenerative Medicine (Volume 5) (Deadline: 28 February 2025)
• Advances in Rare Diseases Biomarkers: 2nd Edition (Deadline: 28 February 2025)
• Advanced Research in Retina: 3rd Edition (Deadline: 28 February 2025)
• Advances of Molecular Research in Reproductive Endocrinology (Deadline: 28 February 2025)
• The Immunometabolic Cross-Talk in Complications of Metabolic Syndrome and Diabetes (Deadline: 28 February 2025)
• Extracellular Vesicles (EVs) in Cancer Progression and Metastasis: Molecular Insights and Clinical Outlook (Deadline: 15 March 2025)
• Breast Cancer: Molecular Pathology, Diagnosis, and Therapeutic Strategies (Deadline: 15 March 2025)
• Recent Molecular Research on Preeclampsia (Deadline: 15 March 2025)
• Molecular Impact of Nicotine on COVID-19 (Deadline: 15 March 2025)
• Molecular Pathogenesis of Oral Potentially Malignant Disorders Transformation (Deadline: 15 March 2025)
• Molecular and Cellular Research in Pregnancy-Related Complications, 2nd Edition (Deadline: 20 March 2025)
• Molecular Research in Rheumatoid Arthritis (Deadline: 20 March 2025)
• Mitochondria-Mediated Oxidative Stress in Diseases: Cell Death and Treatment (Deadline: 20 March 2025)
• Molecular Advances in Mental Health and Disorders (Deadline: 20 March 2025)
• The Roles of Mesenchymal Stem/Stromal Cells in Tumor Therapies (Deadline: 20 March 2025)
• Molecular Mechanisms and Cell Biology of Pancreatic Diseases (Deadline: 20 March 2025)
• Inflammatory Diseases: From a Molecular Perspective (Deadline: 20 March 2025)
• Oral Cancer: Update on Molecular Pathology, Mechanisms and Treatments (Deadline: 20 March 2025)
• Molecular Advances in Gestational Diabetes Mellitus (Deadline: 20 March 2025)
• Molecular Insights into Transplantation and Machine Perfusion (Deadline: 20 March 2025)
• Molecular Pharmacology and Interventions in Cardiovascular Disease (Deadline: 20 March 2025)
• Apoptosis and Autophagy as Strategies in Cancer Treatment (Deadline: 20 March 2025)
• Cystic Fibrosis: Molecular Pathogenesis, Diagnosis, and Treatment (Deadline: 20 March 2025)
• Molecular Research on Platelet Activity in Health and Disease 2024 (Deadline: 20 March 2025)
• Advances and Challenges of Molecular Research on Disease in Animal Models in Biomedicine (Deadline: 20 March 2025)
• Rheumatoid Arthritis: Molecular Mechanisms and Immunotherapy (Deadline: 20 March 2025)
• Ovarian Dysfunction, Infertility and Its Treatment (Deadline: 20 March 2025)
• Targeting Corneal Wound Healing: Molecular Access to Diagnosis, Pathophysiology, and Treatment (Deadline: 20 March 2025)
• Protein Methyltransferases in Human Health and Diseases (Deadline: 20 March 2025)
• Molecular Research Progress of Skin and Skin Diseases: 2nd Edition (Deadline: 20 March 2025)
• Chronic Inflammation: Pathophysiological Process and Nutritional Interventions (Deadline: 20 March 2025)
• Recent Advances and Insights in Treatment of Urinary Tract Diseases (Deadline: 20 March 2025)
• Exploring the Pathogenetic Mechanisms in Respiratory Virus Infections: Recent Advances and Future Directions (Deadline: 20 March 2025)
• Heartfulness: Contributors of Healthy and Unhealthy Cardiac Aging (Deadline: 20 March 2025)
• Mucopolysaccharidoses: Diagnosis, Treatment and Management 4.0 (Deadline: 20 March 2025)
• Molecular Mechanisms and Therapies in Skeletal Muscle Diseases (Deadline: 20 March 2025)
• Molecular Mechanisms and Regulation in Chronic Kidney Diseases (Deadline: 20 March 2025)
• Exploring the Glioblastoma Complexity: New Perspectives in the Molecular and Imaging Fields (Deadline: 20 March 2025)
• Molecular Mechanisms Underlying the Progression of Prostate Cancer (Deadline: 20 March 2025)
• Advanced Research Progress of Blood-Brain Barrier (Deadline: 20 March 2025)
• Innovative Delivery Technologies for Nucleic Acid Therapeutics: From In Vitro to In Vivo Applications (Deadline: 20 March 2025)
• New Advances in Neural Therapeutic Application of Mesenchymal Stem Cells (Deadline: 20 March 2025)
• Molecular Advances in Artificial Reproduction and Female Health: From Molecular Diagnosis to the Treatment of Gynecological Diseases (Deadline: 20 March 2025)
• Biomarkers of Lung Disorders (Deadline: 25 March 2025)
• Integrated Approaches, Molecular Mechanism and Therapies in Ocular Surface Diseases (Deadline: 25 March 2025)
• Roles and Mechanisms of Non-Coding RNAs in Breast Cancer (Deadline: 25 March 2025)
• Navigating Lung Cancer in the Era of Cancer Pharmacology and Precision Therapy (Deadline: 25 March 2025)
• Molecular Research on Type 1 Diabetes and Its Complications: 2nd Edition (Deadline: 29 March 2025)
• Diabetes: Genetics and Genomics, Hormone Regulation, and Metabolic Control (Deadline: 30 March 2025)
• Pathogenesis and Treatment of Prostate Cancer (Deadline: 30 March 2025)
• Heart Failure and Cardiac Remodeling: Molecular Mechanisms and Therapeutic Strategies (Deadline: 30 March 2025)
• Quadruplex DNA and Its Ligands for Disease Treatment (Deadline: 30 March 2025)
• Molecular Pathology, Diagnostics, and Therapeutics in Optic Neuropathies (Deadline: 31 March 2025)
• Molecular Advances in Kidney Transplantation (Deadline: 31 March 2025)
• Advances in Diabetic Ischemic Heart Failure (Deadline: 31 March 2025)
• Gynecologic Diseases: From Molecular Basis to Therapy (Deadline: 31 March 2025)
• Liver Fibrosis: Molecular Pathogenesis, Diagnosis and Treatment (Deadline: 31 March 2025)
• Novel Therapeutic Strategies in Diabetes (Deadline: 31 March 2025)
• Cytokine Networks in Inflammatory Skin Diseases (Deadline: 31 March 2025)
• Molecular Research of Human Fertility (Deadline: 31 March 2025)
• Molecular Insights into Pathogen Dynamics: Enhancing One Health Surveillance (Deadline: 31 March 2025)
• The Extracellular Matrix in Physiopathology (Deadline: 31 March 2025)
• Recent Progress in Metabolic Diseases (Deadline: 31 March 2025)
• New Therapies and Strategies in the Treatment of Neurodegenerative Diseases (Deadline: 31 March 2025)
• Gynecologic Oncology: Molecular Mechanisms and Therapies (Deadline: 31 March 2025)
• Recent Advances of Biochemistry and Molecular Biology of Infectious Diseases, 2nd Edition (Deadline: 31 March 2025)
• Advances in the Pathophysiology and Treatment of Diabetic Retinopathy (Deadline: 31 March 2025)
• Musculoskeletal Disorders: From Molecular Pathology to Novel Therapeutic Approach (Deadline: 31 March 2025)
• The Zebrafish Model in Animal and Human Health Research, 2nd Edition (Deadline: 31 March 2025)
• The Role of Extracellular Matrix Proteins in Pathogenesis: 2nd Edition (Deadline: 31 March 2025)
• Novel Technologies in the Study of the Pathogenesis of Cardiac Diseases (Deadline: 31 March 2025)
• Advances in Molecular Therapeutics for HIV Co-Infections (Deadline: 31 March 2025)
• Physiology and Pathophysiology of Placenta: 3rd Edition (Deadline: 31 March 2025)
• Molecular Insights to Improve Outcomes of Pregnancy Complications (Deadline: 10 April 2025)
• Molecular Immunity and Defense: Oral and Periodontal Health (Deadline: 20 April 2025)
• Cancer Models: Development and Applications (Deadline: 20 April 2025)
• Biomolecules in the Treatment of Biofilm-Related Diseases (Deadline: 20 April 2025)
• Molecular Advances in Skin Diseases 3.0 (Deadline: 20 April 2025)
• Diabetes: From Molecular Basis to Therapy, 2nd Edition (Deadline: 20 April 2025)
• Molecular Research in Chronic Kidney Disease (Deadline: 20 April 2025)
• Rare Diseases: A Diagnostic and Therapeutic Challenge (Deadline: 20 April 2025)
• Hearing Loss: Molecular Biological Insights (Deadline: 20 April 2025)
• The Role of microRNA in Human Diseases 3.0 (Deadline: 20 April 2025)
• Thyroid Disorders: Molecular Mechanisms and Advanced Therapies (Deadline: 20 April 2025)
• Novel Approaches to Potential COVID-19 Molecular Therapeutics (Deadline: 20 April 2025)
• Molecular and Cellular Mechanisms of Spinal Cord Injury and Repair (Deadline: 25 April 2025)
• Effects of Ionizing Radiation in Cancer Radiotherapy: 2nd Edition (Deadline: 25 April 2025)
• Heart Failure Risk Factors and Therapies-Molecular Basis (Deadline: 30 April 2025)
• Molecular Studies in Aging, 2nd Edition (Deadline: 30 April 2025)
• Bile Acids and Bile Acid Modifications in Health and Disease (Deadline: 30 April 2025)
• New Perspectives on Prostate Cancer Occurrence, Diagnosis, and Treatment (Deadline: 30 April 2025)
• Molecular and Cellular Mechanisms in Cardiomyopathy (Deadline: 30 April 2025)
• Cellular and Molecular Progression of Cardiovascular Diseases (Deadline: 30 April 2025)
• Cardiovascular Diseases: Molecular Mechanisms and Potential Therapy (2nd Edition) (Deadline: 26 May 2025)
• Exosomes and Non-Coding RNA Research in Health and Disease (Deadline: 11 June 2025)
• Long-COVID and Its Complications (Deadline: 4 December 2025)

Topical Collections

Following topical collections within this section are currently open for submissions:

• Cardiomyopathies: Molecular Insights and Future Perspectives
• Cardiovascular Diseases in Basic Research: New Molecular Insights and Perspectives
• Feature Papers in Molecular Pathology, Diagnostics, and Therapeutics
• Immunopathology and Immunosenescence
• Molecular Understanding of the Exocrine Pancreas and Its Disorders
• Natural Products and Gut Microbiota in Age-Related Diseases
• Programmed Cell Death and Apoptosis (Closed)
• State-of-the-Art Molecular Mechanisms and Pathophysiology of Cardiovascular and Cerebrovascular Diseases in Italy (Closed)
• State-of-the-Art Molecular Mechanisms and Pathophysiology of Head and Neck Diseases in Australia (Closed)
• State-of-the-Art Molecular Mechanisms of Hematopathology in France (Closed)
• State-of-the-Art Molecular Mechanisms of Pulmonary Pathology in USA (Closed)